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Abstract Staphylococcus aureus strain CH-91, isolated
from a broiler chicken with atopic dermatitis, has a highly
proteolytic phenotype that is correlated with the disease. We
describe the isolation and biochemical and molecular char-
acterization of the AI-type lantibiotic BacCH91 from S.
aureus CH-91 culture medium. The bacteriocin was purified
using a three-stage procedure comprising precipitation with
ammonium sulfate, extraction with organic solvents, and
reversed-phase HPLC. The BacCH91 peptide is thermosta-
ble and highly resistant to cleavage by both prokaryotic and
eukaryotic peptidases. The MIC for the Gram-positive bac-
teria ranged from 2.5 nM for Microococcus luteus through
1.3–6.0 μM for staphylococcal strains up to more than
100 μM for Lactococcus lactis. BacCH91 was ineffective
against the Gram-negative strains tested at the maximal
concentration (100 μM). The amino acid sequence of
BacCH91 is similar to that of epidermin and gallidermin.
The encoding gene (bacCH91) occurred in two allelic var-
iants distinguishable in the restriction fragment length poly-
morphism assay. Variant I, identified in S. aureus CH-91,
dominated in S. aureus strains of poultry origin, although
strains with variant II were also identified in this group. S.
aureus strains of human origin were characterized exclu-
sively by variant II.
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Introduction
Staphylococcus aureus is a common opportunistic pathogen
of humans and other warm-blooded animals. The bacterium
is responsible for a variety of infections, constituting an
important veterinary and public health issue associated with
a substantial economic burden. The increasing antibiotic
resistance of this bacterium is of major concern and has
prompted studies on its pathophysiology.
Despite their broad host diversity, adaptation of individual
strains to particular hosts occurring by acquisition of host-
specific gene pools and/or loss of dispensable genetic material
has been suggested in recent studies (Herron-Olson et al. 2007;
Lowder et al. 2009). S. aureus strain CH-91 was initially isolated
from a broiler chicken with atopic dermatitis (Kuramasu et al.
1967). The disease was correlated with a highly proteolytic
phenotype (Takeuchi et al. 2002) associated with a 17-kb plas-
mid (pCH-91) that is homologous to the poultry-associated
pAvX plasmid (Lowder et al. 2009). Both plasmids encode
cysteine peptidase staphopain C (StpC), an avian host-specific
virulence factor (Wladyka et al. 2011a).
Bacteria produce a wide variety of bioactive peptides, which
among many other factors facilitate their environmental suc-
cess. One of the important functions of bioactive peptides is the
modulation of interactions with co-occurring organisms, most
importantly the host and potential competitors. Staphylococci
secrete a wide range of peptides involved in deregulation of the
host immune response (Dinges et al. 2000; Foster 2005; Postma
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et al. 2004). The range of secreted peptides varies among
strains, and some profiles correlate with a virulent phenotype
(Wang et al. 2007). Bacteria produce a diverse range of poly-
peptides involved in both inter- and intra-species interactions.
Among these, bacteriocins are peptides directed against a vari-
ety of bacteria; hence, they are of special interest, given their
potential use in medicine and the food industry (Galvez et al.
2007; Gillor and Ghazaryan 2007). Staphylococci provide a
rich source of diverse bacteriocins. To date, five such peptides
(Pep5, epidermin, epicidin 280, epilancin K7, and epidermicin
NI01) have been characterized from Staphylococcus epidermi-
dis (Heidrich et al. 1998; Kaletta et al. 1989; Sandiford and
Upton 2011; Schnell et al. 1988; van de Kamp et al. 1995).
Among other bacteriocins, gallidermin was isolated from
Staphylococcus gallinarum (Kellner et al. 1988), hominicin
was isolated from Staphylococcus hominis (Kim et al. 2010),
and nukacin ISK-1 was isolated from Staphylococcus warneri
(Sashihara et al. 2000). Strains of S. aureus have also been
shown to produce bacteriocins, including the two-peptide lanti-
biotic staphylococcin C55 (Navaratna et al. 1998), the closely
related staphylococcin BacR1 (Crupper et al. 1997), the
tryptophan-rich aureocin A53 (Netz et al. 2002, 2001), and
aureocin A70. Contradictory reports exist concerning the pres-
ence of epidermin homologues in S. aureus (Daly et al. 2010;
Joo et al. 2011). Intriguingly, with the exception of gallidermin,
the genes encoding the bacteriocins noted above are located on
plasmids, often together with genes determining antibiotic re-
sistance or encoding virulence factors.
Here, we describe the isolation and biochemical character-
ization of bacteriocin BacCH91 from S. aureus strain CH-91
and show for the first time the ability of S. aureus to produce the
epidermin-like lantibiotic. Cloning of the encoding gene
bacCH91 and a comparative sequence analysis facilitated iden-
tification of a unique allelic variant of bacCH91 associated with
S. aureus strains originating from poultry.
Materials and methods
Bacterial strains and growth conditions
S. aureus CH-91 was kindly provided by S. Takeuchi from
Fukui Prefectural University, Japan (Takeuchi et al. 1999). The
strain has been deposited in the DSMZ collection under the
number DSM 26258. Bacillus licheniformis NCTC 7224, Ba-
cillus subtilis ATCC 6633, Lactococcus lactis subsp. lactis
LOCK 0869, Micrococcus luteus strains DSMZ 20030 and
CBM (clinical isolate), Sarcina lutea ATCC 9341, S. aureus
strains ATCC 25923, M-122 (Polakowska et al. 2012), New-
man and RN4220, S. epidermidis ATCC 35347, Staphylococ-
cus in termedius ATCC 29666, Staphy lococcus
pseudintermedius LMG 22219 (Devriese et al. 2005), Staphy-
lococcus saprophyticus ATCC 49453, Staphylococcus xylosus
strains isolated from the skin of healthy chickens, Streptococcus
mutans ATCC 25175, Streptococcus pneumoniae ATCC
49619,Escherichia coliK12ATCC 10798,Klebsiella pneumo-
niae, Serratia marcescens, and Sphingomonas sp. AMC 3962
(Dziga et al. 2012) were obtained from the collections of The
Faculty of Biochemistry, Biophysics and Biotechnology,
Jagiellonian University, Krakow, Poland. A list of strains used
for assessment of the general occurrence of the bacteriocin gene
is provided in the Electronic supplementary materials (ESM;
Table S1). Gram-positive and Gram-negative bacteria were
maintained at 37 °C in tryptic soy broth (TSB) and Luria-
Bertani broth (both obtained from Sigma), respectively. To
determine the minimal inhibitory concentration (MIC) doses,
all bacteria were cultivated in cation-adjusted Mueller-Hinton
broth (MHB, Sigma) or, in the case of Streptococcus spp. and
L. lactis, grown on agar-solidified MHB supplemented with
2.5 % lysed horse blood (LHB, Graso).
Purification of bacteriocin
Bacteriocin BacCH91 was purified from S. aureus CH-91
culture supernatant. The bacteria were cultivated in TSB at
37 °C and 200 rpm shaking for 18 h. The culture was
centrifuged at 17,000×g for 15 min at 4 °C. The supernatant
was acidified to pH 3.0 using 5 M HCl and then precipitated
with ammonium sulfate to 80 % saturation at 4 °C. The
precipitated material was recovered by centrifugation at
17,000×g for 30 min at 4 °C. The pellet was dissolved in
water and freeze-dried. The resulting dry powder was
extracted for 5 min in a mixture of chloroform and methanol
(2:1, v/v) with vigorous shaking at room temperature (RT).
The extract was clarified by centrifugation (13,000×g for
5 min at RT). The clear supernatant was removed and dried
in a centrifugal evaporator. The dry extract was dissolved in
water containing 27 % (v/v) acetonitrile and 0.09 % (v/v)
trifluoroacetic acid (TFA), and the resulting preparation was
filtered through a 0.45-μm centrifugal filter and subjected to
high-performance liquid chromatography (HPLC) separation
on a LC-8 column (150×4.6 mm; 3 μm particle size; Supelco)
using a buffer system comprising buffers A (0.1 % TFA; v/v)
and B (0.07 % TFA in 80 % acetonitrile; v/v), with a linear
gradient from 40 to 80 % buffer B over 20 min at 1 ml/min.
Fractions containing BacCH91 were detected by measuring
absorbance at 220 and 280 nm, collected, dried in a centrifugal
evaporator, dissolved in water, and stored at −20 °C until
further use.
Protein chemistry techniques
Chemical derivatization to enable detection of modified
amino acids in the bacteriocin molecule during N-terminal
sequencing was performed according to Meyer et al. (1994).
In brief, water was evaporated from the BacCH91 solution
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in a centrifugal evaporator. The bacteriocin was re-dissolved
in a solution containing 46 % ethanol (v/v), 10 % ethanethiol
(v/v), and 0.5 M NaOH. The preparation was purged with
argon and sealed. Following incubation for 2 h at 50 °C, the
preparation was acidified with glacial acetic acid, vortexed,
and used for N-terminal amino acid sequencing.
The N-terminal amino acid sequence was determined in an
automatic protein sequencer (Procise 491; Applied Biosys-
tems) using Edman degradation of the polypeptide chains.
The polybrene-coated glass fiber discs were used for sample
immobilization according to the manufacturer’s instructions.
Amino acid analysis was performed according to White
et al. (1986). In brief, bacteriocin was hydrolyzed in the gas
phase over 6 M HCl at 115 °C for 24 h. The liberated amino
acids were converted to phenylthiocarbamyl derivatives and
analyzed by HPLC (PicoTag 150×3.9 mm column; Waters).
The total protein concentration was estimated using the
bicinchoninic acid assay (BCA, Sigma).
Electrospray ionization mass spectrometry (ESI-MS) was
carried out using an HCT Ultra mass spectrometer (Bruker)
equipped with an electrospray source and an ion trap
analyzer.
Tris-tricine sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS–PAGE) was carried out under reduc-
ing conditions using peptide-separating gels, according to
the protocol of Schagger and von Jagow (1987). Following
electrophoresis, the gels were fixed for 30 min in a mixture
of 50 % methanol (v/v) and 10 % acetic acid (v/v), and
stained with Coomassie Brilliant Blue R-250.
Determination of MIC doses
The bactericidal activity of BacCH91 was determined using
the micro-dilution method in compliance with Clinical and
Laboratory Standards Institute guidelines M7-A7 (CLSI
2006). Briefly, the bacteria were either cultivated in cation-
adjusted MHB to the early exponential phase or grown over-
night on agar-solidified MHB supplemented with 2.5 % LHB
in the case of Streptococcus spp. and L. lactis. Subsequently,
the bacteria were diluted to 1×106CFU/ml either in MHB or
in MHB supplemented with 5 % LHB, in the case of the latter
bacteria. Fifty-microliter portions of bacterial suspension were
mixed with an equal volume of MHB containing serial two-
fold dilutions of bacteriocin. After overnight incubation
at 37 °C, the optical density (OD) at 600 nm was
measured. The MIC was defined as the minimum bac-
teriocin concentration for which the increase in OD was
not observed compared to uninoculated broth.
Radial diffusion assay
For pH, temperature, and protease resistance assays, the
residual activity of BacCH91 was determined using the
radial diffusion assay (Lemos Miguel et al. 2008). In brief,
plates were prepared containing 200× diluted overnight
culture of S. lutea ATCC 9341 in TSB agar (1 %, w/v).
Wells (2.4 mm diameter) were cut in the agar and filled with
10 μl of the BacCH91 preparation for testing. Following
overnight incubation at 37 °C, the residual activity was
measured as the diameter of inhibition zones.
Influence of pH, temperature, and proteases on the activity
of BacCH91
To test the pH stability of BacCH91, a water solution of the
bacteriocin (final concentration, 30 μM) was evaporated in a
vacuum centrifuge and re-dissolved in (a) 100 mM sodium
citrate pH 3.0, 4.0, 5.0, and 6.0; (b) 100 mMTris–HCl pH 7.0,
8.0, and 9.0; and (c) 100 mM 3-cyclohexylamino-1-propane-
sulphonic acid-NaOH pH 10.0 and 11.0. The solutions were
incubated for 3 h at RT, and the residual activity of the
bacteriocin was determined using the radial diffusion assay.
The temperature stability of BacCH91 (30 μM final concen-
tration) was determined in 50 mM Tris–HCl pH 7.4, 0.15 M
NaCl and 50mM bis-Tris pH 6.4, 0.15MNaCl. The solutions
were incubated for 1, 6, and 24 h at 37, 60, 80, and 99 °C. The
residual activity of the bacteriocin was determined with the
radial diffusion assay using S. lutea as an indicator strain.
We evaluated the susceptibility of BacCH91 to proteolysis
by aureolysin; staphopains A, B, and C; V8 peptidase
(Biocentrum); bovine alpha-chymotrypsin and TPCK-treated
trypsin (Sigma); human elastase and cathepsin G (Biocentrum);
pepsin from porcine gastric mucosa (Sigma); and proteinase K
(A&A Biotechnology). Dried samples of BacCH91 were dis-
solved to a final concentration of 30 μM in the following
buffers: 100 mM bis-Tris pH 6.4 or Tris–HCl pH 7.5, each
containing 5 mM CaCl2 (aureolysin, chymotrypsin, and tryp-
sin); 100 mM bis-Tris pH 6.4 or Tris–HCl pH 7.5, each con-
taining 5 mM cysteine hydrochloride and 5 mM EDTA
(staphopains A, B, and C); 100 mM bis-Tris pH 6.4 or Tris–
HCl pH 7.5 (elastase); 100 mM bis-Tris pH 6.4 or Tris–HCl
pH 7.5, each containing 200 mMNaCl (cathepsin G); 100 mM
bis-Tris pH 6.4 or 100 mM sodium phosphate pH 6.4 and
pH 7.8 (V8 peptidase); and 100 mM sodium citrate pH 3.2
(pepsin). The peptidases were added in the ratio 1:20 (enzyme/
bacteriocin) by weight, and the mixtures were incubated for 1 h
at 37 °C. The residual activity was determined with the radial
diffusion assay using S. lutea as an indicator strain, and the
bacteriocin molecule integrity was assessed using HPLC.
All of the above experiments were performed in triplicate.
The final results are presented as means±SD.
Influence of StpC on biosynthesis of BacCH91
S. aureus CH-91 was cultured at 37 °C in TSB supplemented
with the cysteine peptidase inhibitor E-64 (1-[N-[(L-3-trans-
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carboxyoxirane-2-carbonyl)-L-leucyl] amino]-4-guanidinobu-
tane; Sigma) at final concentrations of 1.0, 0.1, and 0.01 mM.
Aliquots were removed at 5, 10, and 24 h, and the bacteria-
free supernatants were obtained by centrifugation.
To estimate the level of BacCH91, the collected super-
natants were acidified with TFA (1 % final concentration, v/
v) and filtered (0.45 μm filter). Aliquots (30 μl) were ana-
lyzed using HPLC (Kromasil C4 column, 250×4.6 mm;
Supelco) and the same buffers as those used during the
purification procedure. The column was flushed for 5 min
following injection at a constant concentration of 34 % B. A
linear gradient from 34 to 100 % B was then applied over
10 min at 1 ml/min. Under these conditions, BacCH91 was
detected at 220 nm as a single peak eluting with a retention
time of 14.6 min. The relative amount of bacteriocin was
calculated as the area under the peak.
The residual proteolytic activity of collected culture me-
dia was determined at 37 °C using Hide Powder Azure
(Calbiochem) in 0.1 M Tris–HCl (pH 7.5) supplemented
with 5 mM cysteine and 5 mM EDTA.
Determination of the bacteriocin coding sequence
The coding sequence for BacCH91 and its flanking
regions was determined using standard molecular biolo-
gy methods (Sambrook et al. 1989). Briefly, the amino
acid sequence of bacteriocin determined using Edman
sequencing was compared with sequences in the Nation-
al Center for Biotechnology Information (NCBI) data-
base (http://www.ncbi.nlm.nih.gov), using the BLASTp
algorithm. Based on the matching genomic sequences
obtained, we designed a set of primers flanking the
region of interest. Amplicons obtained by PCR using
S. aureus CH-91 genomic DNA were cloned into
pTZ57R/T (Fermentas). The plasmids were sequenced
across the inserts. The contig sequence was edited using
Genedoc 2.0 software (Nicholas et al. 1997) and deposited in
the GenBank (accession number JQ655767).
Determination of the distribution of the bacteriocin gene
The distribution of the bacteriocin gene among the staphy-
lococcal strains was determined using PCR. For PCR, the
primers flanking the bacteriocin gene, i.e., bacteruniqueF
(5′-TTAGTGAAAATAAATAGTA) and bacterrewR (5′-
CATTTGTAAGCACCTCAC), were used under the follow-
ing PCR cycling conditions: 1 cycle at 94 °C for 2 min,
30 cycles at 94 °C for 30 s, 42 °C for 30 s, and 72 °C for
45 s. Strains positive for bacCH91 were further assayed to
assess the occurrence of the allelic variant of bacCH91. The
PCR product was directly treated with the restriction en-
zyme BcuI (Fermentas). The restriction fragments were
separated using 2 % agarose gel electrophoresis. Restriction
pattern I consisted of 271 and 128 bp products of a single
cleavage, whereas restriction pattern II was characterized by
an uncleaved amplicon of 399 bp.
Results
Purification and biochemical characterization of bacteriocin
BacCH91
BacCH91 was purified from the culture supernatant of S.
aureus CH-91 using a three-stage procedure comprising
precipitation with ammonium sulfate, extraction with organ-
ic solvents, and reversed-phase HPLC on a C8 column.
Using the optimized gradient, the bacteriocin eluted at ap-
proximately 11.5 min (Fig. 1). The preparation obtained was
homogenous, as evidenced by SDS–PAGE (Fig. 1), ESI-
MS, and N-terminal sequencing (data not shown). The pu-
rification procedure yielded 1 mg purified BacCH91 from
1 L of culture supernatant (10 % overall yield; Table 1).
Based on ESI-MS, the molecular mass of the purified
bacteriocin was estimated at 2,074.9 Da. Direct N-terminal
Edman degradation allowed only partial determination of
the first six residues: Ile-X-X-Phe-Ile-Gly, where X denotes
an unknown residue. Identification of amino acid residues at
positions 2, 3, 7, and subsequent positions was not possible
in the standard setup, suggesting posttranslational modifica-
tion of side chains or unusual intramolecular bonds, both of
which commonly occur in lantibiotics. Identification of
residues at positions 2, 3, 7, and subsequent positions was
possible only after the chemical derivatization of the bacte-
riocin with ethanethiol under alkaline conditions. The full
21-mer sequence of BacCH91 was found to be Ile-
bmeSeCys-SeCys-Phe-Ile-Gly-SeCys-bmeSeCys-Pro-Gly-
X-Gly-Lys-bmeSeCys-Gly-SeCys-Phe-Asn-SeCys-Phe-
SeCys, where X is an unknown residue, bmeSeCys is beta-
methyl-S-ethylcysteine (a reaction product of ethanethiol
with 2,3-didehydro-2-aminobutyric acid or 3-methyl-
lanthionine), and SeCys is S-ethyl-cysteine (a reaction prod-
uct of ethanethiol with 2,3-didehydroalanine or lanthionine).
Antibacterial activity
The bactericidal activity of the purified BacCH91 was deter-
mined for a range of Gram-positive andGram-negative bacteria
using the micro-dilution assay. The bacteria tested included 11
strains of staphylococci, 7 strains of other Gram-positive bac-
teria, and 5 Gram-negative species (Table 2). With the excep-
tion of L. lactis, for which the determined MIC was over
100 μM, all the Gram-positive bacteria tested were susceptible
to BacCH91. Among the microorganisms tested, M. luteus
strains exhibited the highest susceptibility to the bacteriocin
(2.5 and 40 nM for DSMZ 20030 and CBM, respectively). For
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other Gram-positive bacteria, the MICs ranged from a 0.31 μM
for S. lutea to 6.0 μM for various S. aureus strains. Interesting-
ly, the bacteriocin-producing strain S. aureus CH-91 was also
susceptible to BacCH91 (MIC 1.3 μM). None of the Gram-
negative species assayed were susceptible to BacCH91, even at
the highest concentration tested (100 μM).
Effect of pH, temperature, and peptidases on BacCH91
activity
The effect of pH on the activity of BacCH91 was studied in
the range pH 3–11. Purified bacteriocin retained full bacte-
ricidal activity during incubation for 3 h at pH 3.0–6.0
(Fig. 2b). Incubation at pH 7.0 and higher pH values caused
a gradual loss of bactericidal activity, and complete inacti-
vation occurred at pH 11.0.
The effect of temperature on the activity of BacCH91 was
studied at pH 6.4 and pH 7.4. The bacteriocin was incubated at
37, 60, 80, and 99 °C, and the residual activity was determined
using the radial diffusion assay and S. lutea as an indicator strain
(Fig. 2a). BacCH91maintained its activity for 1 h at temperatures
up to 80 °C. Even short incubation at 99 °C or several hours of
incubation at temperatures higher than 60 °C resulted in complete
inactivation of the bacteriocin. The temperature-induced inacti-
vation was associated with hydrolysis of the polypeptide chain as
evidenced by HPLC and ESI-MS analyses (not shown).
The susceptibility of BacCH91 to proteolysis was studied at
pH 6.4 and at the optimum pH for each of the enzymes tested.
Following incubation with each enzyme, the residual bacteri-
cidal activity was determined using the radial diffusion assay,
and the integrity of BacCH91 was analyzed using HPLC. None
of the proteases tested (see “Materials and methods” section)
affected the activity or integrity of BacCH91, including all of
the staphylococcal extracellular peptidases tested.
Influence of StpC on the biosynthesis and stability
of BacCH91
S. aureus strain CH-91 secretes large quantities of cysteine
peptidase StpC, an enzyme that constitutes the major component
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Fig. 1 HPLC purification of BacCH91. The chloroform/methanol
extract of the precipitated culture medium was separated on a C8
column. The arrow indicates the homogenous bacteriocin peak. The
inserts contain the SDS–PAGE image of the culture medium (M),
chloroform/methanol extract (CME), and the respective fractions from
the C8 column
Table 1 Summary of the purification process of BacCH91 bacteriocin















Culture supernatant 500 5.65 2,825 19.35 54,664 100 1
Ammonium sulfate
precipitation
29.9 7.65 228.7 55.99 12,805 23.4 2.89
Organic extract 3.85 17.0 65.5 92.08 6,031 11.0 4.76
HPLC 1 0.548 0.548 10,220 5,600 10.2 528
a The protein concentration was routinely determined using the BCA. Only for the final peptide preparation (following HPLC) was the
concentration measured by amino acid analysis
b One unit of bactericidal activity (units) was arbitrarily defined as the amount of bacteriocin resulting in an inhibition zone of 1 cm diameter, as
determined in the radial diffusion assay
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of the extracellular, soluble proteome of the bacterium (Wladyka
et al. 2011b). It was therefore of interest to determine the effect of
the enzyme on the biosynthesis and stability of BacCH91 in vivo.
The bacteriawere cultured in liquidmedium in the presence of E-
64, a specific irreversible inhibitor of cysteine peptidases. Sam-
ples of the culture medium were collected after 5, 10, and 24 h,
and the amount of bacteriocin was estimated by HPLC. The
amount of BacCH91 was the same for all concentrations of the
E-64 tested (0.01, 0.1, and 1.0 mM) and in the control medium
(no inhibitor added). StpC inhibition was tested in parallel using
the chromogenic protein substrate. No residual proteolytic activ-
ity was detected in the culture media containing the inhibitor,
thereby confirming its effectiveness. This experiment indicated
that StpC is dispensable for posttranslational maturation of
BacCH91 and confirmed that the peptidase does not affect the
stability of the lantibiotic.
Characterization of the gene encoding BacCH91
and its localization in the staphylococcal genome
The sequence of BacCH91 obtained using Edman degradation
was aligned with staphylococcal genomic data using the
BLASTp algorithm in the NCBI database. An open reading
frame (ORF) encoding an identical sequence was identified in
three S. aureus strains (RF122, LGA 251, and ED133), all of
which were isolated from animals. Additional matches of
lesser similarity (but differing only at several positions) were
identified in strains of human origin, but also in RF122, LGA
251, and ED133, indicating the presence of two genes encod-
ing similar bacteriocins in the genomes of some S. aureus
strains. The sequence encoding BacCH91 is not present in the
genome of strain ED98, which was isolated from chicken, or
other sequenced S. aureus genomes. This indicates that the
bacCH91 gene is not a part of the core genome but rather a
part of an accessory genetic pool.
To determine the precise location and neighborhood of
bacCH91 in the genetic material of S. aureus CH-91, a
2-kbp fragment flanking the gene was amplified and se-
quenced. The analysis of the obtained sequence demonstrated
that the gene encoding leukotoxin D (lukD) was located 861
nucleotides upstream of bacCH91, while lbpB, a gene coding
for a lantibiotic biosynthesis protein B, was located 64 nucleo-
tides downstream of bacCH91 (Fig. 3). Although the neigh-
borhood of bacCH91 resembles that of the other
staphylococcal bacteriocins identified during this study and
described in the published staphylococcal genomes, signifi-
cant differences were also found. Other staphylococcal lanti-
biotic gene clusters encode two very similar bacteriocins,
whereas only a single gene (bacCH91) was present in S.
aureus CH-91 (Fig. 3a). Moreover, a sequence with no ho-
mology to any database sequence was found downstream of
lukD in strain CH-91. This sequence was approximately
200 bp long and ended with 13-nucleotide inverted repeats.
Downstream of this sequence in strain CH-91, instead of the
bac1 lantibiotic gene found in the other strains of staphylo-
cocci, we identified an ORF (hyp) that encodes an 86-amino
acid polypeptide havingmoderate homology to the C-terminal
part of the staphylococcal IstB-like ATP-binding protein fol-
lowed by bacCH91 (a bac2 homologue). Downstream of
bacCH91, an 11-nucleotide perfect IR identical to that found
downstream of bac2 in the other strains was identified.
Occurrence of the lantibiotic gene allele in S. aureus strains
Analysis of available genomic data revealed that bacCH91
homologues (bac2) occur in two conserved allelic variants
(Fig. 3 and ESM Fig. S1). A lantibiotic gene identical to that
of strain CH-91 was found in only three strains of S. aureus
(RF122, LGA 251, and ED133), all of which were isolated
from cows, whereas neither bac1 nor bac2 was present in
the ED98 strain, which is of chicken origin. An allelic
variant of bac2 was identified in some strains isolated from
humans (other human strains had neither bac1 nor bac2).
The identified alleles of bac2 differ in the presence of a BcuI
(SpeI) site, which conveniently facilitated identification
Table 2 Antibacterial activity (MIC) of BacCH91 towards selected
Gram-positive and Gram-negative strains
Strain MIC (μM)
Bacillus licheniformis NCTC 7224 1.8
Bacillus subtilis ATCC 6633 2.6
Lactococcus lactis subsp. lactis LOCK 0869 >100
Micrococcus luteus DSMZ 20030 0.0025
Micrococcus luteus CBM 0.04
Sarcina lutea ATCC 9341 0.31
Staphylococcus aureus ATCC 25923 6.0
Staphylococcus aureus CH91a 1.3
Staphylococcus aureus M-122 4.0
Staphylococcus aureus Newmana 6.0
Staphylococcus aureus RN4220a 6.0
Staphylococcus epidermidis ATCC 35347 1.6
Staphylococcus intermedius ATCC 29663 1.6
Staphylococcus pseudintermedius LMG 22219 1.5
Staphylococcus saprophiticus ATCC 49453 3.0
Staphylococcus xylosus kw 2,5b 1.5–2.0
Streptococcus mutans ATCC 25175 2.0
Streptococcus pneumoniae ATCC 49619 1.6
Escherichia coli K12 ATCC 10798 >100
Klebsiella pneumoniae >100
Pseudomonas aeruginosa ATCC 27853 >100
Serratia marcescens >100
Sphingomonas sp. AMC 3962 >100
a Bacteriocin gene positive strain
b Two representative strains from a single herd were tested
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using restriction fragment length polymorphism (RFLP)
analysis (Fig. 3b, c). To assess the general occurrence of
allelic variants, 58 S. aureus strains were tested, including
21 of human origin and 37 isolated from animals. PCR
products (399 bp) containing the lantibiotic gene (Fig. 3b),
obtained using the bacteruniqueF and bacterrewR primers,
were treated with BcuI, and the restriction products were
analyzed using electrophoresis. A total of 23 strains (11 of
human origin and 12 of animal origin) were positive for the
bac2 gene (Table 3 and ESM Table S1). The type I restric-
tion pattern characteristic of strain CH-91 was found in 8 of
the 12 bacteriocin-positive strains isolated from animals but
in none of the 11 bacteriocin-positive strains of human
origin. With respect to the strains isolated from poultry, 9
of the 20 strains were positive for the lantibiotic gene, with
seven strains exhibiting a type I restriction pattern. It is
noteworthy that the two remaining strains with a type II
restriction pattern were MRSA strains, while all the other
poultry strains were MSSA.
Discussion
The BacCH91 reported here is the first AI-type lantibiotic
isolated from S. aureus and thoroughly characterized. Exis-
tence of a gene coding for similar bacteriocin was previously
reported (Daly et al. 2010), but the described properties of a
corresponding peptide were questioned by Joo et al. (2011).
The former authors claimed to have identified a respective
peptide in culture supernatants of S. aureus based on mass
spectrometry data. The identification was however doubtful
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Fig. 2 Temperature and pH
stability of BacCH91. a
Residual bactericidal activity of
bacteriocin following treatment
for the indicated times at the
indicated temperatures and pH.
b Residual bactericidal activity
3 h following bacteriocin
exposure to buffers of the
indicated pH. A radial diffusion
assay with the S. lutea indicator
strain was used to determine the
residual bactericidal activity.
For other experimental details,
see “Materials and methods”
section
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and collaborators noticed that the molecular mass of the
antimicrobial agent identified by Daly was in perfect agree-
ment with proteolytically processed phenol soluble modulin,
also exhibiting pronounced antimicrobial activity. Therefore,
the identity of the antimicrobial agent characterized by Daly
and colleagues remains uncertain.
The BacCH91 bacteriocin was purified from culture
supernatants of strain CH-91 using a procedure originally
designed for bacterial hemolytic peptides (Mak et al. 2008).
The relatively hydrophobic character of the peptide facili-
tated effective extraction using an optimized mixture of
organic solvents, and a single subsequent chromatography
step (reversed-phase HPLC) produced a homogenous bac-
teriocin preparation. This procedure is much less time-
consuming than the procedures that have been used by
others to purify similar peptides. Although the yield
(10 %) was not as high as that reported for some bacterio-
cins (e.g., 19 % for staphylococcin T), it was still higher
than that reported for other bacteriocin isolation procedures
(e.g., 1 % for mutacin B-Ny266) (Furmanek et al. 1999;
Mota-Meira et al. 1997). Determination of the amino acid
sequence of BacCH91 using Edman degradation required
chemical modification of multiple residues, as previously
reported for other lantibiotics (Meyer et al. 1994). The
results of chemical sequencing were confirmed by cloning
of the bacteriocin gene. Based on the sequence obtained,
BacCH91 was classified in the epidermin group of AI-type
lantibiotics, which includes peptide epidermin; Val1-Leu6-
epidermin; gallidermin; staphylococcin T; mutacins B-
Ny266, 1140, I and III; and streptin (Bierbaum and Sahl
2009; Chatterjee et al. 2005). BacCH91 is most closely
related to epidermin and gallidermin (Fig. 4). Significantly,
the fourth residue was phenylalanine in BacCH91 but lysine
in both epidermin and gallidermin, which explains the more
hydrophobic character of BacCH91.
The MICs of BacCH91 for various bacterial species
clearly demonstrated that the bacteriocin was effective only
against Gram-positive microorganisms, however not against
L. lactis. Among the species tested, M. luteus exhibited the
highest susceptibility to BacCH91. The MIC determined for
this species (2.5 nM for the strain DSMZ 20030 and 40 nM
for the strain CBM) is comparable with the value obtained
for closely related galidermin (Ottenwalder et al. 1995),
which indicates that at least one likely target bacterial
Fig. 3 Chromosome organization in the vicinity of the bacCH91 gene.
a Schematic organization of the chromosome region containing the
bacteriocin gene in S. aureus CH-91 and other S. aureus strains. Note:
some strains were devoid of bacteriocin genes and the entire region
downstream of lukD was organized very differently, which is not
shown here. ORFs are shadowed gray. Putative promoter regions are
indicated with the bent arrows. The primers used for amplification of
the bacteriocin allele are indicated by straight arrows. Inverted repeats
are indicated by “IR” and a double triangle symbol. b Agarose gel
showing an example RFLP result for two allelic variants of the
bacCH91 (bac2) gene. c Nucleotide and amino acid sequence of the
pre-peptide of BacCH91. An arrowhead indicates the beginning of the
mature form. The line above the sequence indicates the cleavage site
for BcuI, which was used for determining the allelic variants
Table 3 Occurrence of allelic
variants of the bacteriocin gene
among S. aureus strains
aPercent of bacteriocin gene
positive strains among all tested
strains
bPercent of the respective restric-
tion pattern among bacteriocin
gene positive strains
Strain origin S. aureus strain Detectable bacteriocin gene Restriction pattern
I II
Quantity % Quantity % Quantity % Quantity %
Human 21 36.2 11 52.4 0 0 11 100
Poultry 20 34.5 9 45.0 7 77.8 2 22.2
Non-poultry 17 29.3 3 17.6 1 33.3 2 66.6
Total 58 100 23 39.7a 8 34.8b 15 65.2b
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species has been identified. The high susceptibility of M.
luteus to bacteriocin produced by S. aureus has possible
biological relevance since both bacteria are residents of
mammalian skin and nasal mucosa. Therefore, it is likely
that the bacteriocin-producing staphylococcal strains have
an advantage in competing for the same ecological niche
with Micrococcus sp. The MIC values for Staphylococcus
spp. did not differ significantly among species and strains,
and they were most comparable to the MIC for S. aureus
strain CH-91. This indicates that BacCH91 action is not
directed against other, non-bacteriocin-producing staphylo-
coccal strains.
No differences in the temperature stability of BacCH91
were observed between neutral pH and pH 6.4, which is
typical of chicken skin (Bhaduri and Cottrell 2004). Simi-
larly to other lantibiotics, the bacteriocin from S. aureus
strain CH-91 was stable at elevated temperatures (almost
100 % activity was retained during incubation for 1 h at 80 °
C) and resistant to proteolytic inactivation. The bacteriocin
was not affected by any of the staphylococcal peptidases
tested, particularly StpC, which is abundantly produced by
strain CH-91. This was expected as it was assumed that
secretory peptides would not be inactivated by proteases
secreted by the same microorganism into the same environ-
mental niche. Surprisingly, BacCH91 was unaffected by
trypsin and proteinase K. This result differs from that
obtained in previous studies of AI-type epidermin-like and
nisin-like lantibiotics which are typically cleaved by trypsin,
although only after prolonged incubation (Kellner et al.
1988; Kuipers et al. 1993).
Lantibiotics are ribosomally synthesized peptides that
undergo extensive posttranslational modification, including
proteolytic processing of the leader peptide. It has been
demonstrated that as many as three extracellular peptidases
(subtilisin, WprA, and Vpr) are involved in maturation of
subtilin, produced by B. subtilis ATCC 6633 (Corvey et al.
2003). Other antimicrobial peptides require activation by
endogenous extracellular peptidases (Faye et al. 2002).
Since BacCH91 is produced by a highly proteolytic
strain, it was important to assess whether StpC, the
major extracellular peptidase of strain CH-91, is en-
gaged in maturation of bacteriocin. Inhibition of StpC
activity during bacterial growth using a specific irrevers-
ible inhibitor of cysteine peptidases (E-64) had no effect
on the level of BacCH91, suggesting an StpC-
independent maturation mechanism. This finding is con-
sistent with the recently reported substrate specificity of
StpC for bulky uncharged amino acid residues (Kalinska
et al. 2012); in turn, the BacCH91 leader peptide is
processed after a charged residue (Fig. 3c).
Since BacCH91 is the first AI-type lantibiotic character-
ized from S. aureus, we assessed whether identical or ho-
mologous lantibiotics were present in other strains. The
database search revealed that a gene encoding an identical
bacteriocin was present in S. aureus strains isolated from
cows. Moreover, highly homologous genes were found in
some strains of human origin, whereas many strains of both
human and animal origin completely lacked genes homolo-
gous to bacCH91. Therefore, it was concluded that
bacCH91 is accessory to the core genome of staphylococci.
This is of particular importance since accessory genetic
material has been implicated in virulence and host specific-
ity of staphylococci (Lowder et al. 2009). The genomic
localization of bacCH91 contrasts with other identified
staphylococcal bacteriocin genes, which are all located on
plasmids (Bierbaum et al. 1996). Analysis of staphylococcal
genomic data demonstrated that bacteriocins identical or
closely related to BacCH91 were encoded in tandem repeats
(Daly et al. 2010). Only strain CH-91 exhibited unique
organization of the region involved, with only a single
bacCH91 gene being present, while the second bacteriocin
gene was substituted by an ORF encoding a polypeptide
similar to proteins that are thought to be involved in recom-
bination of genetic material (Solinas et al. 1995; Fig. 3a).
This indirectly suggests the origin of the observed genetic
rearrangement. In all the cases, the gene encoding a lanti-
biotic biosynthesis protein (LbpB) was located downstream
of bacCH91 (bac2). This organization is comparable to that
of a cluster of genes driving the biosynthesis of the homol-
ogous lantibiotic epidermin, produced by S. epidermidis
DSM 3095 (Schnell et al. 1992).
It was demonstrated that bacCH91 occurred in two
allelic variants distinguishable by RFLP. The allelic
variant I identified in S. aureus CH-91 was characteris-
tic for the strains of poultry origin and was not present
in any of the strains of human origin tested. The iso-
lates of human origin were characterized by allelic
variant II, which was also detected in several strains
of animal origin. Therefore, the simple RFLP assay may
serve as a useful tool for tracing the transmission of
staphylococcal strains among hosts.
Fig. 4 Alignment of the amino acid sequences of AI-type lantibiotics.
Identical residues are indicated by dots
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